The aim of this study was to evaluate the efficacy and safety of Tripterygium Wilfordii Hook F (TWHF) in DN patients with overt proteinuria and normal eGFR.124 eligible DN patients were randomly assigned into two groups to receive either valsartan 160 mg/d